These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2241262)

  • 1. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.
    Jose PJ; Moss IK; Maini RN; Williams TJ
    Ann Rheum Dis; 1990 Oct; 49(10):747-52. PubMed ID: 2241262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
    Moxley G; Ruddy S
    Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid.
    Høgåsen K; Mollnes TE; Harboe M; Götze O; Hammer HB; Oppermann M
    J Rheumatol; 1995 Jan; 22(1):24-8. PubMed ID: 7535360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic activity for polymorphonuclear and mononuclear leukocytes in rheumatoid synovial fluids.
    Okamoto T; Ueda K; Kambara T; Kutsuna T
    Acta Pathol Jpn; 1986 Aug; 36(8):1109-22. PubMed ID: 3776528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.
    Abbink JJ; Kamp AM; Nuijens JH; Erenberg AJ; Swaak AJ; Hack CE
    Ann Rheum Dis; 1992 Oct; 51(10):1123-8. PubMed ID: 1444625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
    PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
    Hasselbacher P
    Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid factor in serum and synovial fluid.
    MacSween RN; Dalakos TK; Jasani MK; Buchanan WW
    Scand J Rheumatol; 1972; 1(4):177-80. PubMed ID: 4663999
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing activity of rheumatoid synovial fluid.
    Townes AS; Marcus RL
    Ann Rheum Dis; 1972 Sep; 31(5):393-401. PubMed ID: 5071634
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis.
    Hermann E; Fleischer B; Mayet WJ; Poralla T; Meyer zum Büschenfelde KH
    Clin Exp Rheumatol; 1989; 7(4):411-4. PubMed ID: 2591114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.
    Elmgreen J; Hansen TM
    Ann Rheum Dis; 1985 Aug; 44(8):514-8. PubMed ID: 4026413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
    Peltier AP; Vial MC; Leroy C; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus antibodies in serum and synovial fluid of patients with rheumatoid arthritis and other connective tissue diseases.
    Kalliomäki JL; Halonen P; Salmi A
    Ann Rheum Dis; 1975 Feb; 34(1):43-8. PubMed ID: 1124954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement is activated in the upper respiratory tract during influenza virus infection.
    Bjornson AB; Mellencamp MA; Schiff GM
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1062-6. PubMed ID: 2024815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis].
    Hermann E; Vogt P; Hagmann W; Dunky A; Müller W
    Z Rheumatol; 1988; 47(1):20-5. PubMed ID: 3259355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.